Scott M. Friedman

5.8k total citations · 3 hit papers
48 papers, 3.6k citations indexed

About

Scott M. Friedman is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Neurology. According to data from OpenAlex, Scott M. Friedman has authored 48 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Ophthalmology, 22 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Neurology. Recurrent topics in Scott M. Friedman's work include Retinal Diseases and Treatments (25 papers), Retinal Imaging and Analysis (18 papers) and Retinal and Optic Conditions (16 papers). Scott M. Friedman is often cited by papers focused on Retinal Diseases and Treatments (25 papers), Retinal Imaging and Analysis (18 papers) and Retinal and Optic Conditions (16 papers). Scott M. Friedman collaborates with scholars based in United States, Israel and Lebanon. Scott M. Friedman's co-authors include Neil M. Bressler, Adam R. Glassman, Michael J. Elman, Frederick L. Ferris, Roy W. Beck, Jennifer K. Sun, Cynthia R. Stockdale, Ingrid U. Scott, Lloyd Paul Aiello and Allison R. Edwards and has published in prestigious journals such as New England Journal of Medicine, JAMA and Clinical Infectious Diseases.

In The Last Decade

Scott M. Friedman

45 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

2010 1.1k citations Michael J. Elman, Lloyd Paul Aiello et al. Ophthalmology profile →
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy

2015 529 citations Jeffrey G. Gross, Adam R. Glassman et al. JAMA profile →
Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

2011 430 citations Michael J. Elman, Neil M. Bressler et al. Ophthalmology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott M. Friedman United States	22	3.3k	2.6k	370	157	79	48	3.6k
Andrew W. Eller United States	21	1.1k 0.3×	698 0.3×	317 0.9×	131 0.8×	93 1.2×	70	1.4k
Banu Öztürk Türkiye	19	482 0.1×	295 0.1×	226 0.6×	105 0.7×	42 0.5×	118	1.2k
Clara C. Chan Canada	29	1.2k 0.4×	2.1k 0.8×	142 0.4×	184 1.2×	8 0.1×	172	2.9k
Nina Hautala Finland	19	273 0.1×	187 0.1×	296 0.8×	72 0.5×	17 0.2×	54	1000
JOHN STAIGE DAVIS United States	19	117 0.0×	310 0.1×	169 0.5×	136 0.9×	32 0.4×	59	1.1k
Claudia Mendoza‐Pinto Mexico	25	177 0.1×	117 0.0×	188 0.5×	159 1.0×	68 0.9×	100	1.6k
J Wong Hong Kong	21	256 0.1×	239 0.1×	68 0.2×	552 3.5×	28 0.4×	53	2.0k
V. J. McCann Australia	17	85 0.0×	106 0.0×	109 0.3×	87 0.6×	49 0.6×	34	917
Solveig Tenckhoff Germany	13	125 0.0×	101 0.0×	227 0.6×	114 0.7×	18 0.2×	30	848
J. Sydney Stillman United States	14	109 0.0×	101 0.0×	188 0.5×	76 0.5×	40 0.5×	23	1.4k

Countries citing papers authored by Scott M. Friedman

Since Specialization

Citations

This map shows the geographic impact of Scott M. Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott M. Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott M. Friedman more than expected).

Fields of papers citing papers by Scott M. Friedman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott M. Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott M. Friedman. The network helps show where Scott M. Friedman may publish in the future.

Co-authorship network of co-authors of Scott M. Friedman

This figure shows the co-authorship network connecting the top 25 collaborators of Scott M. Friedman. A scholar is included among the top collaborators of Scott M. Friedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott M. Friedman. Scott M. Friedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Friedman, Scott M., Nikolas London, Ágnes Kerényi, et al.. (2025). Randomized Trial of Biosimilar ABP 938 Compared with Reference Aflibercept in Adults with Neovascular Age-Related Macular Degeneration. Ophthalmology Retina. 10(2). 152–164.

Friedman, Scott M., et al.. (2025). Aflibercept 8 mg versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials. Ophthalmology and Therapy. 14(11). 2919–2936.

Nguyen, Alexander T., et al.. (2024). Cost analysis of dropless cataract surgery prophylaxis with intracameral antibiotics and subconjunctival steroids. Journal of Cataract & Refractive Surgery. 50(12). 1215–1223. 4 indexed citations

Begaj, Tedi, Scott M. Friedman, Avnish Deobhakta, et al.. (2024). Geographic Atrophy Natural History Versus Treatment: Time to Fovea. Ophthalmic surgery, lasers & imaging retina. 55(10). 576–585. 1 indexed citations

Bressler, Susan B., Allison R. Ayala, Neil M. Bressler, et al.. (2016). Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment. JAMA Ophthalmology. 134(3). 278–278. 156 indexed citations

Gross, Jeffrey G., Adam R. Glassman, Lee M. Jampol, et al.. (2015). Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy. JAMA. 314(20). 2137–2137. 529 indexed citations breakdown →

Elman, Michael J., Neil M. Bressler, Haijing Qin, et al.. (2011). Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema. Ophthalmology. 118(4). 609–614. 430 indexed citations breakdown →

Loewenstein, Anat, Yaron Lang, Ayala Pollack, et al.. (2010). TOWARD EARLIER DETECTION OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION. Retina. 30(7). 1058–1064. 33 indexed citations

Friedman, Scott M., et al.. (2010). BILATERAL VASCULAR OCCLUSIONS OF THE ANTERIOR VISUAL PATHWAY AND COCAINE ABUSE. Retinal Cases & Brief Reports. 4(2). 95–98. 3 indexed citations

10.

Ip, Michael S., Susan B. Bressler, Andrew N. Antoszyk, et al.. (2008). A Randomized Trial Comparing Intravitreal Triamcinolone and Focal/Grid Photocoagulation for Diabetic Macular Edema. Retina. 28(7). 919–930. 32 indexed citations

11.

Scott, Ingrid U., Allison R. Edwards, Neil M. Bressler, et al.. (2007). A Phase II Randomized Clinical Trial of Intravitreal Bevacizumab for Diabetic Macular Edema. Ophthalmology. 114(10). 1860–1867.e7. 344 indexed citations

12.

Friedman, Scott M. & Curtis E. Margo. (2006). Topical Gel vs Subconjunctival Lidocaine for Intravitreous Injection: A Randomized Clinical Trial. American Journal of Ophthalmology. 142(5). 887–888. 22 indexed citations

13.

Friedman, Scott M.. (2005). RETINAL VASCULITIS AS THE INITIAL PRESENTATION OF MULTIPLE SCLEROSIS. Retina. 25(2). 218–219. 4 indexed citations

14.

Rechtman, E., Alon Harris, Louis B. Cantor, et al.. (2003). An update on retinal circulation assessment technologies. Current Eye Research. 27(6). 329–343. 42 indexed citations

15.

Mansour, Ahmad M., Haytham I. Salti, Scott M. Friedman, et al.. (2000). Ocular Findings in Aplastic Anemia. Ophthalmologica. 214(6). 399–402. 49 indexed citations

16.

Friedman, Scott M. & Curtis E. Margo. (2000). Choroidal neovascular membranes: reproducibility of angiographic interpretation. American Journal of Ophthalmology. 130(6). 839–841. 31 indexed citations

17.

Ormerod, L. David, Peter R. Pavan, Jeffrey P. Nadler, et al.. (1998). Rapidl y Progressiv e Herpeti c Retina l Necrosis : A Blindin g Diseas e C of Advance dDS. Clinical Infectious Diseases. 26(1). 34–45. 42 indexed citations

18.

Blinder, Kevin J., Scott M. Friedman, & Robert N. Mames. (1995). Diabetic Iris Neovascularization. American Journal of Ophthalmology. 120(3). 393–395. 10 indexed citations

19.

Friedman, Scott M.. (1995). Bilateral Central Retinal Vein Occlusions in a Patient With Acquired Immunodeficiency Syndrome. Archives of Ophthalmology. 113(9). 1184–1184. 23 indexed citations

20.

Mames, Robert N., Scott M. Friedman, & Gary C. Brown. (1992). DISTRIBUTION OF THE POSTERIOR CILIARY ARTERIES REVEALED AFTER VASCULAR OCCLUSIONS. Retina. 12(4). 367–369. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact